Scientific advances in cancer research and new means of diagnosis and treatment have made it possible to cure many patients. The probability of cure depends largely on the type of cancer tumor and the stage at which the disease is discovered. Accurate means of diagnosis in the early stages is key to saving lives.
New Israeli research by Isotopia Molecular Imaging Ltd., and led by Prof. Sharon Ruthstein from the Department of Chemistry at Bar-Ilan University, is being conducted to develop a hypoxia radioactive marker, a phenomenon of lack of oxygen in cells, based on the Copper 64 isotope to identify oxygen-deficient cells. Read More.
